Total Asset Turnover
since 2013
Calculation
IQVIA Holdings Inc., total asset turnover, long-term trends, calculation
| Total asset turnover | = | Revenues1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|
| Dec 31, 2022 | 0.57 | = | 14,410) | ÷ | 25,337) |
| Dec 31, 2021 | 0.56 | = | 13,874) | ÷ | 24,689) |
| Dec 31, 2020 | 0.46 | = | 11,359) | ÷ | 24,564) |
| Dec 31, 2019 | 0.48 | = | 11,088) | ÷ | 23,251) |
| Dec 31, 2018 | 0.46 | = | 10,412) | ÷ | 22,549) |
| Dec 31, 2017 | 0.43 | = | 9,739) | ÷ | 22,742) |
| Dec 31, 2016 | 0.32 | = | 6,878) | ÷ | 21,208) |
| Dec 31, 2015 | 1.46 | = | 5,738) | ÷ | 3,926) |
| Dec 31, 2014 | 1.65 | = | 5,460) | ÷ | 3,306) |
| Dec 31, 2013 | 1.66 | = | 5,100) | ÷ | 3,067) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 US$ in millions
The financial data indicates a significant structural shift in the company's asset base and revenue generation capabilities between 2013 and 2022. While revenues exhibited consistent growth over the decade, the efficiency of asset utilization underwent a period of severe contraction followed by a gradual recovery.
- Revenue Growth Trends
- Revenues increased steadily from 5,100 million US dollars in 2013 to 14,410 million US dollars by 2022. The growth trajectory was particularly pronounced between 2016 and 2017, where revenues rose from 6,878 million to 9,739 million US dollars, marking a substantial expansion in top-line performance.
- Asset Base Expansion
- A critical inflection point occurred between December 31, 2015, and December 31, 2016, during which total assets surged from 3,926 million to 21,208 million US dollars. This sharp increase suggests a major capital expansion or acquisition event. Following this spike, the asset base remained relatively stable, ending the period at 25,337 million US dollars in 2022.
- Total Asset Turnover Analysis
- The total asset turnover ratio experienced a dramatic decline, falling from 1.46 in 2015 to 0.32 in 2016. This collapse correlates directly with the massive increase in total assets, which outpaced revenue growth in the short term. Since 2016, a consistent recovery trend is observed, with the ratio improving from 0.32 to 0.57 by 2022. This upward movement indicates an increasing ability to generate revenue from the expanded asset base, although the ratio remains significantly lower than the pre-2016 levels.
The overall pattern suggests that the organization transitioned from a lean asset model to a capital-intensive model. The subsequent gradual increase in the asset turnover ratio demonstrates a phased improvement in operational efficiency as the company integrated and optimized its larger asset portfolio.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
IQVIA Holdings Inc., total asset turnover, long-term trends, comparison to competitors
| IQVIA Holdings Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | 0.57 | 0.42 | 0.38 | 0.48 | 0.37 | 0.58 | 0.43 | 0.51 | 0.54 | 0.51 | 0.42 | 0.46 | 0.49 |
| Dec 31, 2021 | 0.56 | 0.38 | 0.40 | 0.42 | 0.35 | 0.58 | 0.40 | 0.52 | 0.46 | 0.45 | 0.63 | 0.41 | 0.56 |
| Dec 31, 2020 | 0.46 | 0.30 | 0.39 | 0.36 | 0.29 | 0.53 | 0.36 | 0.47 | 0.52 | 0.28 | 0.50 | 0.47 | 0.53 |
| Dec 31, 2019 | 0.48 | 0.37 | 0.37 | 0.20 | 0.29 | 0.57 | 0.36 | 0.52 | 0.55 | 0.31 | 0.53 | 0.44 | 0.50 |
| Dec 31, 2018 | 0.46 | 0.55 | 0.34 | 0.64 | 0.42 | 0.56 | 0.34 | 0.53 | 0.51 | 0.34 | 0.57 | 0.43 | 0.49 |
| Dec 31, 2017 | 0.43 | 0.40 | 0.27 | 0.62 | 0.39 | 0.51 | 0.37 | 0.49 | 0.46 | 0.31 | 0.67 | 0.37 | 0.70 |
| Dec 31, 2016 | 0.32 | 0.39 | 0.28 | 0.58 | 0.37 | 0.55 | 0.53 | 0.51 | 0.42 | 0.31 | 0.70 | 0.40 | 0.59 |
| Dec 31, 2015 | 1.46 | 0.43 | 0.29 | 0.52 | 0.43 | 0.56 | 0.62 | 0.53 | 0.39 | 0.29 | 0.73 | 0.41 | 0.41 |
| Dec 31, 2014 | 1.65 | 0.72 | 0.28 | 0.47 | 0.54 | 0.53 | 0.71 | 0.57 | 0.43 | 0.29 | 0.73 | 0.39 | 0.25 |
| Dec 31, 2013 | 1.66 | 0.64 | 0.28 | 0.42 | 0.55 | 0.66 | 0.48 | 0.54 | 0.42 | 0.30 | 0.71 | 0.41 | 0.52 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
IQVIA Holdings Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| IQVIA Holdings Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2022 | 0.57 | 0.47 |
| Dec 31, 2021 | 0.56 | 0.45 |
| Dec 31, 2020 | 0.46 | 0.39 |
| Dec 31, 2019 | 0.48 | 0.39 |
| Dec 31, 2018 | 0.46 | 0.45 |
| Dec 31, 2017 | 0.43 | 0.40 |
| Dec 31, 2016 | 0.32 | 0.41 |
| Dec 31, 2015 | 1.46 | 0.42 |
| Dec 31, 2014 | 1.65 | 0.44 |
| Dec 31, 2013 | 1.66 | 0.43 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
Comparison to Industry (Health Care)
IQVIA Holdings Inc., total asset turnover, long-term trends, comparison to industry (health care)
| IQVIA Holdings Inc. | Health Care | |
|---|---|---|
| Dec 31, 2022 | 0.57 | 0.66 |
| Dec 31, 2021 | 0.56 | 0.62 |
| Dec 31, 2020 | 0.46 | 0.57 |
| Dec 31, 2019 | 0.48 | 0.57 |
| Dec 31, 2018 | 0.46 | 0.63 |
| Dec 31, 2017 | 0.43 | 0.56 |
| Dec 31, 2016 | 0.32 | 0.57 |
| Dec 31, 2015 | 1.46 | 0.55 |
| Dec 31, 2014 | 1.65 | 0.60 |
| Dec 31, 2013 | 1.66 | 0.58 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).